Matches in Wikidata for { <http://www.wikidata.org/entity/Q66396686> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q66396686 description "clinical trial" @default.
- Q66396686 description "ensayu clínicu" @default.
- Q66396686 description "klinisch onderzoek" @default.
- Q66396686 description "клінічне випробування" @default.
- Q66396686 name "A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in NSCLC Patients With EGFR Mutation Who Failed 1L or 2L EGFR TKI Therapy" @default.
- Q66396686 name "A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in NSCLC Patients With EGFR Mutation Who Failed 1L or 2L EGFR TKI Therapy" @default.
- Q66396686 type Item @default.
- Q66396686 label "A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in NSCLC Patients With EGFR Mutation Who Failed 1L or 2L EGFR TKI Therapy" @default.
- Q66396686 label "A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in NSCLC Patients With EGFR Mutation Who Failed 1L or 2L EGFR TKI Therapy" @default.
- Q66396686 prefLabel "A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in NSCLC Patients With EGFR Mutation Who Failed 1L or 2L EGFR TKI Therapy" @default.
- Q66396686 prefLabel "A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in NSCLC Patients With EGFR Mutation Who Failed 1L or 2L EGFR TKI Therapy" @default.
- Q66396686 P1132 Q66396686-5081974E-95F0-42D8-8C41-06255E733ACE @default.
- Q66396686 P131 Q66396686-3E0DEE98-07B2-401F-B670-37F7542ABE14 @default.
- Q66396686 P1476 Q66396686-C7AEBF34-BB61-4554-9FF4-0745E8493394 @default.
- Q66396686 P17 Q66396686-5D88A311-3D92-4884-9C42-44A5FE858D2A @default.
- Q66396686 P17 Q66396686-80E5B5DB-BB9B-4383-BFCD-004A1C13285E @default.
- Q66396686 P17 Q66396686-884D62A5-87B8-4107-A587-837B9AD78D48 @default.
- Q66396686 P17 Q66396686-8BE48A7B-2827-4E28-B409-711355887F0E @default.
- Q66396686 P17 Q66396686-AD368AB6-199B-43E8-8B20-4A4B07289C58 @default.
- Q66396686 P17 Q66396686-C1408614-1965-4FEE-99A6-3FBF43E0D72F @default.
- Q66396686 P17 Q66396686-FBDC8F50-DD26-4EE6-B8DF-48B0E370A111 @default.
- Q66396686 P1813 Q66396686-E3FA2B75-6242-4EB5-9E88-87D62F2F49B4 @default.
- Q66396686 P2899 Q66396686-B71FC0DA-8699-43CA-B351-A60958EEB5D9 @default.
- Q66396686 P3098 Q66396686-C453B13C-AA21-4AC4-9DA3-0E3019825851 @default.
- Q66396686 P31 Q66396686-FDAB0C97-76DC-4828-BD4A-43D72C3BFDD7 @default.
- Q66396686 P4844 Q66396686-2527F9FB-3BBD-4236-A846-BDCA11AF8D5B @default.
- Q66396686 P4844 Q66396686-2E6D3D6F-7D20-4090-92D6-91CDD09A21D5 @default.
- Q66396686 P580 Q66396686-69BA5E99-C4E8-46F8-A905-F7A8FC10B858 @default.
- Q66396686 P582 Q66396686-B0FD74D9-9633-41CC-901D-CB5069F9AFBA @default.
- Q66396686 P6099 Q66396686-E7BA0822-FF96-4901-9359-19C85BA062FA @default.
- Q66396686 P8363 Q66396686-D5D7B71F-B9A5-4903-8410-48395C54DAEC @default.
- Q66396686 P859 Q66396686-8D4328A9-C83B-4832-AD0B-268EF821045E @default.
- Q66396686 P1132 "+580" @default.
- Q66396686 P131 Q8646 @default.
- Q66396686 P1476 "Open-Label, Randomized Trial of Nivolumab (BMS-936558) Plus Pemetrexed/Platinum or Nivolumab Plus Ipilimumab (BMS-734016) vs Pemetrexed Plus Platinum in Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) Subjects With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor Therapy" @default.
- Q66396686 P17 Q142 @default.
- Q66396686 P17 Q16 @default.
- Q66396686 P17 Q17 @default.
- Q66396686 P17 Q29 @default.
- Q66396686 P17 Q30 @default.
- Q66396686 P17 Q334 @default.
- Q66396686 P17 Q865 @default.
- Q66396686 P1813 "CheckMate722" @default.
- Q66396686 P2899 "+18" @default.
- Q66396686 P3098 "NCT02864251" @default.
- Q66396686 P31 Q30612 @default.
- Q66396686 P4844 Q415220 @default.
- Q66396686 P4844 Q415588 @default.
- Q66396686 P580 "2016-10-20T00:00:00Z" @default.
- Q66396686 P582 "2021-09-30T00:00:00Z" @default.
- Q66396686 P6099 Q42824827 @default.
- Q66396686 P8363 Q78089383 @default.
- Q66396686 P859 Q266423 @default.